A pesticide still legally sprayed on strawberries, apples, citrus, soybeans, and wheat in most U.S. states has been linked to a more than 2.5-fold increased risk of developing Parkinson's disease — and a landmark study from UCLA Health has now identified, for the first time, exactly how it causes that damage.
The findings, published in the journal Molecular Neurodegeneration and receiving renewed scientific attention following a June 28, 2026, press push by UCLA and ScienceDaily, build what researchers describe as one of the strongest cases yet that chlorpyrifos — an organophosphate insecticide from the same chemical family as nerve agents — does not merely correlate with Parkinson's disease but likely contributes to causing it.
Nearly one million Americans live with Parkinson's disease, a progressive neurological disorder for which there is no cure and no treatment that stops disease progression.
Why This Matters
This study matters for two reasons that go beyond the usual association-based pesticide research.
First, the UCLA team did not merely identify a statistical link between chlorpyrifos exposure and Parkinson's — they identified the precise biological mechanism: the pesticide disables the brain's autophagy system, a cellular cleanup process that normally removes toxic, misfolded proteins from neurons. When autophagy is disrupted, a protein called alpha-synuclein accumulates in dopamine-producing neurons — which is exactly the pathological hallmark of Parkinson's disease.
Second, chlorpyrifos is still on the market and still on your produce. Despite the EPA banning residential use in 2001 and restricting agricultural use in 2021, the chemical remains legal for use on approximately 11 food and feed crops in the United States, including alfalfa, apples, citrus, strawberries, soybeans, and wheat. A final EPA rule that would eliminate most remaining uses is expected later in 2026, though its timeline may shift.
What We Know So Far
The UCLA study combined two research tracks: a human epidemiological study and laboratory experiments. The human study enrolled 829 clinically confirmed Parkinson's patients and 824 healthy controls. Researchers assessed long-term residential proximity to chlorpyrifos agricultural applications as a proxy for cumulative exposure.
People with documented long-term residential exposure to chlorpyrifos were found to have more than 2.5 times the likelihood of developing Parkinson's disease compared to unexposed individuals.
In parallel laboratory experiments, animals exposed to chlorpyrifos developed:
- Impaired movement and motor function
- Loss of dopamine-producing neurons in brain regions affected by Parkinson's
- Accumulation of the same toxic alpha-synuclein protein aggregates seen in Parkinson's patients' brains
- Disruption of the autophagy pathway — the brain's cellular garbage-disposal system
The combination of human population data and laboratory mechanistic evidence in a single study is unusual and strengthens the scientific confidence in the association.
Where the Risk Is Highest
Agricultural communities in California's Central Valley, Florida's citrus-growing regions, the Pacific Northwest, and the Midwest grain belt have historically had the heaviest chlorpyrifos exposure. People who lived or worked near treated fields for extended periods before current restrictions took effect are considered to be at the highest historical exposure risk.
But exposure is not limited to agricultural workers or rural residents. As a crop-applied pesticide with no required pre-harvest interval data collected for all treated crops, chlorpyrifos residues can remain on produce that reaches grocery stores and kitchen tables in every U.S. city. The USDA's Pesticide Data Program has historically detected chlorpyrifos residues on a range of commercially sold fruits and vegetables.
California, Hawaii, Maryland, and a small number of other states have enacted their own chlorpyrifos bans that go beyond federal restrictions. Residents in those states have fewer ongoing sources of exposure through domestic agricultural use, though imported produce remains a potential source.
What Doctors and Experts Say
"The evidence now points to a likely causal relationship," said Dr. Jeff Bronstein, professor of Neurology at UCLA Health and senior author of the study, in remarks reported by multiple science outlets following the June 28, 2026 press release. Bronstein said the autophagy findings specifically — showing how the pesticide blocks the brain's protein-disposal mechanism — represent a biological argument for causation, not merely correlation.
Researchers noted that people with known historical exposure to chlorpyrifos, particularly those who lived or worked near treated agricultural fields for extended periods, might benefit from closer neurological monitoring. The team also identified the autophagy pathway as a potential therapeutic target: drugs that support cellular cleanup mechanisms could theoretically reduce or slow the brain damage associated with pesticide exposure.
UCLA has also announced a separate $9 million follow-up study, set to begin in 2026 and run through 2029, that will examine how chlorpyrifos and other pesticides interact with air pollutants and genetic risk factors to influence Parkinson's risk in agricultural communities.
What the Evidence Shows — and What It Does Not
The epidemiological component of the UCLA study is observational, not a controlled trial. Residential proximity to agricultural applications of chlorpyrifos served as a proxy for personal exposure — a limitation the researchers acknowledged, since proximity does not perfectly capture individual dose, timing, or concurrent exposures to other pesticides.
The study did not prove that eating produce with chlorpyrifos residues at typical consumer levels causes Parkinson's disease. The exposure pathway in the human study was specifically long-term residential proximity to agricultural fields where chlorpyrifos was applied — an exposure level likely higher than what a consumer receives through dietary intake alone.
However, the mechanistic data from animal and cellular experiments provide the biological plausibility that has historically been missing from association studies of pesticides and Parkinson's. Together, the two tracks of evidence represent the most complete picture of chlorpyrifos and Parkinson's disease biology assembled to date.
MedicalDaily Evidence Check
- Study type : Observational human study + laboratory mechanistic experiments (combined)
- Human participants : 829 Parkinson's patients + 824 healthy controls
- Published in : Molecular Neurodegeneration
- What it found : 2.5-fold increased Parkinson's risk with long-term residential chlorpyrifos exposure; specific disruption of autophagy pathway identified in laboratory models
- What it did not prov e: That dietary residues at consumer levels cause Parkinson's, or that a single exposure creates measurable risk
- What readers should know : People with long-term agricultural field proximity exposure may benefit from neurological monitoring; the EPA's pending rule to eliminate most remaining chlorpyrifos uses is directly relevant to this research
Who Faces the Greatest Risk?
Based on the study's findings, researchers identified the following groups as carrying the highest concern:
- Current and former agricultural workers who applied chlorpyrifos or worked in treated fields
- Residents who lived in close proximity to actively treated fields for extended periods, particularly before 2021 restrictions
- Individuals with genetic risk factors for Parkinson's disease (family history, or specific genetic variants affecting alpha-synuclein handling)
- Older adults who grew up in agricultural regions where chlorpyrifos was widely applied beginning in the 1960s
Researchers noted that organophosphate pesticides similar to chlorpyrifos — many of which remain in widespread use domestically and globally — may operate through similar mechanisms, suggesting the public health relevance of the findings extends beyond chlorpyrifos alone.
Symptoms and Warning Signs to Watch For
Parkinson's disease develops gradually. Early symptoms that may warrant a neurological evaluation include:
- Resting tremor (involuntary shaking of a hand or limb while not in use)
- Gradual stiffness in arms, legs, or trunk
- Slowing of movement (bradykinesia)
- Changes in handwriting (smaller letters, cramped writing)
- Soft or slurred speech
- Reduced facial expression
- Balance difficulty or frequent falls
- Loss of sense of smell (an early but often missed sign)
If you or someone you know has had significant agricultural chemical exposure and develops any of these symptoms, a neurological evaluation is appropriate. No blood test currently exists to diagnose Parkinson's, but neurological examination, brain imaging, and clinical history can support diagnosis and early intervention.
What You Can Do Now
- Wash produce thoroughly. While washing does not eliminate all pesticide residues, it significantly reduces surface residue on fruits and vegetables. The FDA recommends rinsing produce under running water and scrubbing firm produce before eating.
- Consider organic options for high-residue crops. The Environmental Working Group's annual "Dirty Dozen" list identifies the produce categories with the highest conventionally grown pesticide residue levels. Strawberries have historically appeared at or near the top of this list.
- If you have had significant agricultural exposure, discuss it with your doctor. There is no standard screening test for Parkinson's risk, but neurologists can assess baseline motor function and establish a monitoring baseline.
- Follow EPA rule updates. The EPA's expected 2026 final rule on chlorpyrifos would eliminate most remaining domestic agricultural uses. You can track federal pesticide regulation updates at epa.gov/pesticide-tolerances .
- Do not stop eating fruits and vegetables based on this study. The dietary and cardiovascular benefits of produce consumption are well-established and substantial. The exposure of concern in this study was primarily residential agricultural proximity, not routine dietary intake.
Cost and Access: What Patients Should Know
If you or a family member is concerned about pesticide exposure history and neurological health, a referral to a neurologist for a baseline evaluation can typically be obtained through a primary care provider. Most private insurance and Medicare cover neurology consultations when supported by a clinical referral.
The Parkinson's Foundation's helpline (1-800-4PD-INFO) can assist with local specialist referrals, caregiver support resources, and information about clinical trials.
What Happens Next
The EPA's pending final rule on chlorpyrifos is the most consequential near-term development. If finalized as proposed, it would ban most remaining agricultural applications of the chemical on domestic crops — a step that could significantly reduce future exposure in agricultural communities.
UCLA's $9 million follow-up study, running from 2026 through 2029, will examine gene-environment interactions that may explain why some people exposed to chlorpyrifos develop Parkinson's and others do not — a question critical to identifying who should be most closely monitored.
Dr. Bronstein also identified the autophagy pathway as a potential target for future drug development. If compounds that support the brain's protein-disposal system can be developed and tested, they could theoretically slow neurodegeneration in people with early pesticide-related damage — a concept that may be tested in future clinical trials.
The Bottom Line
The UCLA research adds a mechanism to what was previously only an association, moving the science on chlorpyrifos and Parkinson's disease meaningfully closer to a causal argument. For the vast majority of Americans who encounter chlorpyrifos primarily through dietary residue rather than agricultural field proximity, the immediate practical risk is likely low — but the research underscores the importance of the EPA's pending final rule on the chemical's remaining agricultural uses. People with a history of significant occupational or residential agricultural exposure should discuss the findings with a neurologist.
